000 | 01026 a2200289 4500 | ||
---|---|---|---|
005 | 20250514150637.0 | ||
264 | 0 | _c20030501 | |
008 | 200305s 0 0 eng d | ||
022 | _a0022-2143 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPAYNE, R W | |
245 | 0 | 0 |
_aThe value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR). _h[electronic resource] |
260 |
_bThe Journal of laboratory and clinical medicine _cMar 1955 |
||
300 |
_a331-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
650 | 0 | 4 | _aArthritis |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xtherapy |
650 | 0 | 4 | _aBlood Proteins |
650 | 0 | 4 | _aPhenylbutazone |
650 | 0 | 4 |
_aPolysaccharides _xblood |
700 | 1 | _aSHETLAR, M R | |
700 | 1 | _aFARR, C H | |
700 | 1 | _aHELLBAUM, A A | |
700 | 1 | _aISHMAEL, W K | |
773 | 0 |
_tThe Journal of laboratory and clinical medicine _gvol. 45 _gno. 3 _gp. 331-9 |
|
999 |
_c14116131 _d14116131 |